Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Gets $17M Contract from FDA for Food Safety Tools

NEW YORK (GenomeWeb News) – Illumina today said that it has received a $17 million contract from the US Food and Drug Administration to provide sequencing systems and reagents for food safety testing.

Under the five-year contract, Illumina will supply its MiSeq systems and reagents for performing whole-genome analysis on produce and produce-related environmental Salmonella and shigatoxigenic E. coli isolates.

Illumina said in a statement that the FDA already has several MiSeq systems deployed in its labs and is building its existing capacity as part of a proof-of-concept initiative. In addition, it said in the short-term the FDA is looking to collect data that is crucial to source-tracking Salmonella that may be involved in future produce-related outbreaks.

Sequence data collected at the FDA labs will be uploaded in real-time to the National Center for Biotechnology Information curated database and will provide early proof of concept for using whole-genome sequencing for pathogen detection, identification and traceback, said Illumina.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.